ADMA Biologics, Inc. (ADMA)
11.26
+0.18
(+1.62%)
USD |
NASDAQ |
Apr 24, 16:00
11.29
+0.03
(+0.27%)
After-Hours: 20:00
ADMA Biologics Market Cap : 2.682B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.343B |
| Inovio Pharmaceuticals, Inc. | 79.46M |
| ANI Pharmaceuticals, Inc. | 1.789B |
| Eli Lilly & Co. | 789.69B |
| Ligand Pharmaceuticals, Inc. | 4.613B |
Market Cap Related Metrics
| PE Ratio | 18.80 |
| PS Ratio | 5.417 |
| Price to Book Value | 5.618 |
| Price to Free Cash Flow | 100.48 |
| Price | 11.26 |
| Earnings Yield | 5.32% |
| Operating PE Ratio | 14.44 |
| Normalized PE Ratio | 18.50 |